Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Simioni

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutationJ M Brugge, P Simioni, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 20, 2011
Platelet factor V levels in moderate to severe congenital factor V deficiencyL Spiezia, C Radu, C Bulato, et al.
British Journal of Haematology|November 1, 1993
A novel dysfunctional protein C (protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++A Girolami, P Simioni, B Girolami, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 4, 2014
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiencyF Nuzzo, C Bulato, B I Nielsen, et al.
The New England Journal of Medicine|February 6, 1997
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden)P Simioni, P Prandoni, A W Lensing, et al.
Haematologica|July 1, 1997
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patientsP Prandoni, S Villalta, P Bagatella, et al.
Archives of Internal Medicine|October 29, 1997
Recurrence of venous thromboembolism in patients with familial thrombophiliaA G van den Belt, B J Sanson, P Simioni, et al.
Thrombosis and Haemostasis|October 6, 1998
Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasmaE Castoldi, M Kalafatis, B Lunghi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2002
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean areaD Turri, M Rosselli, P Simioni, et al.
Blood|November 9, 2000
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosisP Simioni, P Prandoni, A W Lensing, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutationJ M Brugge, P Simioni, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 20, 2011
Platelet factor V levels in moderate to severe congenital factor V deficiencyL Spiezia, C Radu, C Bulato, et al.
British Journal of Haematology|November 1, 1993
A novel dysfunctional protein C (protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++A Girolami, P Simioni, B Girolami, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 4, 2014
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiencyF Nuzzo, C Bulato, B I Nielsen, et al.
The New England Journal of Medicine|February 6, 1997
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden)P Simioni, P Prandoni, A W Lensing, et al.
Haematologica|July 1, 1997
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patientsP Prandoni, S Villalta, P Bagatella, et al.
Archives of Internal Medicine|October 29, 1997
Recurrence of venous thromboembolism in patients with familial thrombophiliaA G van den Belt, B J Sanson, P Simioni, et al.
Thrombosis and Haemostasis|October 6, 1998
Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasmaE Castoldi, M Kalafatis, B Lunghi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2002
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean areaD Turri, M Rosselli, P Simioni, et al.
Blood|November 9, 2000
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosisP Simioni, P Prandoni, A W Lensing, et al.
Pageof 17